)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Agomab Therapeutics
Agomab Therapeutics (AGMB) investor relations material
Agomab Therapeutics Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary23 Apr, 2026
Executive summary
Achieved significant clinical progress in 2025, including positive topline results from the STENOVA Phase 2a study with ontunisertib in FSCD and positive Phase 1 results for AGMB-447 in healthy participants.
Successfully completed IPO in February 2026, raising $208 million in gross proceeds.
On track to initiate Phase 2b study with ontunisertib in FSCD and Phase 2 study with AGMB-447 in IPF in the second half of 2026.
Expect topline data from OLE study with ontunisertib in FSCD and Phase 1b IPF study cohort with AGMB-447 in the second half of 2026.
Financial highlights
Cash, cash equivalents, and short-term investments totaled €116.5 million as of December 31, 2025.
Gross proceeds of $208 million from IPO in February 2026 expected to fund operations into the first half of 2029.
R&D expenses were €48.9 million for 2025, up from €39.3 million in 2024, mainly due to increased clinical trial costs.
G&A expenses rose to €12.8 million in 2025 from €10.1 million in 2024, reflecting organizational growth.
Net loss for 2025 was €62.5 million, compared to €46.3 million in 2024.
Outlook and guidance
Cash runway expected to extend into the first half of 2029, supported by IPO proceeds.
Anticipates initiating key Phase 2 studies for ontunisertib and AGMB-447 in the second half of 2026.
Topline data from ongoing studies expected in the second half of 2026.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Agomab Therapeutics
Next Agomab Therapeutics earnings date
Q1 202616 Jun, 2026
Agomab Therapeutics
Next Agomab Therapeutics earnings date
Q1 202616 Jun, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage